MedTrace Logo

PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs

NCT04459351 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-08-09

No results posted yet for this study

Summary

PHENOTYPE is an investigator-led, observational cohort study which aims to explore the long-term outcomes of patients with COVID-19 infection and to identify potential risk factors and biomarkers that can prognosticate disease severity and trajectory.

Conditions

  • Coronavirus
  • Corona Virus Infection
  • COVID-19
  • 2019nCoV
  • 2019 Novel Coronavirus Infection

Sponsors & Collaborators

  • Chelsea and Westminster NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Pallav Shah, MBBS, MD · Chelsea and Westminster NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-19
Primary Completion
2023-05-31
Completion
2023-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04459351 on ClinicalTrials.gov